Sep 24 |
Iterum’s oral sulopenem acceptance hinges on antibiotic stewardship efforts
|
Sep 10 |
Iterum stock falls 9% in wake of FDA AdComm meeting on UTI drug
|
Sep 10 |
Iterum Therapeutics Provides Update on FDA Advisory Committee Discussion of Oral Sulopenem for the Treatment of uUTI in Adult Women
|
Sep 6 |
Iterum Therapeutics to Present at the 26th Annual H.C. Wainwright Global Investment Conference
|
Aug 16 |
Iterum Therapeutics plc (ITRM) Q2 2024 Earnings Call Transcript
|
Aug 16 |
When Will Iterum Therapeutics plc (NASDAQ:ITRM) Become Profitable?
|
Aug 14 |
Iterum Therapeutics GAAP EPS of -$0.30 beats by $0.15
|
Aug 14 |
Iterum Therapeutics Reports Second Quarter 2024 Financial Results
|
Aug 13 |
Iterum Therapeutics Q2 2024 Earnings Preview
|
Aug 7 |
Iterum Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024
|